Literature DB >> 11422609

Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger?

Y F Liaw.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11422609     DOI： 10.1046/j.1440-1746.2001.02523.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  7 in total

1.  Clearance of chronic HCV infection during acute delta hepatitis.

Authors:  K Deterding; S V Pothakamuri; V Schlaphoff; J Hadem; F Metzler; M J Bahr; M P Manns; M Cornberg; H Wedemeyer
Journal:  Infection       Date:  2007-12-14       Impact factor: 3.553

2.  Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.

Authors:  Rong-Nan Chien
Journal:  Hepatol Int       Date:  2008-04-10       Impact factor: 6.047

3.  Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa.

Authors:  Samar Ben Halima; Olfa Bahri; Nadia Maamouri; Imed Cheikh; Nissaf Ben Alaya; Amel Sadraoui; Ons Azaiez; Msaddak Azouz; Nabyl Ben Mami; Henda Triki
Journal:  Virol J       Date:  2010-09-15       Impact factor: 4.099

4.  The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.

Authors:  F-C Tseng; B R Edlin; M Zhang; A Kral; M P Busch; B A Ortiz-Conde; T M Welzel; T R O'Brien
Journal:  J Viral Hepat       Date:  2008-05-27       Impact factor: 3.728

Review 5.  Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.

Authors:  Seth D Crockett; Emmet B Keeffe
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-09-13       Impact factor: 3.944

6.  A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort.

Authors:  Yi-Hao Yen; Kwong-Ming Kee; Fang-Ying Kuo; Kuo-Chin Chang; Tsung-Hui Hu; Sheng-Nan Lu; Jing-Houng Wang; Chao-Hung Hung; Chien-Hung Chen
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin.

Authors:  Yi-Hao Yen; Chao-Min Huang; Kuo-Liang Wei; Jing-Houng Wang; Sheng-Nan Lu; Chuan-Mo Lee; Chao-Hung Hung; Chien-Hung Chen; Po-Lin Tseng; Kuo-Chin Chang; Ming-Chao Tsai; Ming-Tsung Lin; Cheng-Kun Wu; Cheng-Hong Yang; Sin-Hua Moi; Chung-Lung Cho; Tsung-Hui Hu
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.